Doliracetam

Doliracetam is a nootropic drug (cognition enhancer) from the racetam family used in treatment of epilepsy.[1][2]

Doliracetam
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: unscheduled
Identifiers
IUPAC name
  • 2-(2-oxo-3-phenyl-3H-indol-1-yl)acetamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC16H14N2O2
Molar mass266.300 g·mol−1
3D model (JSmol)
SMILES
  • C1=CC=C(C=C1)C2C3=CC=CC=C3N(C2=O)CC(=O)N
InChI
  • InChI=1S/C16H14N2O2/c17-14(19)10-18-13-9-5-4-8-12(13)15(16(18)20)11-6-2-1-3-7-11/h1-9,15H,10H2,(H2,17,19) N
  • Key:MVZYGLQQNPFARE-UHFFFAOYSA-N N
 NY (what is this?)  (verify)

According to the Hoechst patent title, it has neuroanabolic action.

See also

References
  1. EP 62887, Kuch, Heinz & Kruse, Hansjörg, "Indolinone-2 derivatives, process for their preparation and neuro-anabolic mediums containing them", published 1982-10-20, assigned to Hoechst AG
  2. Fariello RG, Ghelardini C, Di Cesare Mannelli L, Bonanno G, Pittaluga A, Milanese M, Misiano P, Farina C (June 2014). "Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain". Neuropharmacology. 81: 85–94. doi:10.1016/j.neuropharm.2014.01.029. PMID 24486381.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.